Atossa Therapeutics, Inc. (ATOS) stock
ATOSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.96+0.02 (+1.03%)
Close on Nov 13, 2026Market cap $19.56MP/E –Yield –
Atossa Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Atossa Therapeutics's enterprise value was -$5.84M on Nov 11, 2026, against $48.58M a year earlier. Over the last 5 years it ranged from -$50.26M to $137.08M, with a median of $16.23M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$5.84M | -124.0% |
| 2025 | Dec 31, 2025 | $24.36M | -44.0% |
| 2024 | Dec 31, 2024 | $43.53M | +168.2% |
| 2023 | Dec 29, 2023 | $16.23M | – |
| 2022 | Dec 30, 2022 | -$50.26M | -180.4% |
| 2021 | Dec 31, 2021 | $62.55M | +7394.2% |
| 2020 | Dec 31, 2020 | $834.60K | – |
| 2019 | Dec 31, 2019 | -$954.64K | – |
| 2018 | Dec 31, 2018 | -$7.30M | -900.5% |
| 2017 | Dec 29, 2017 | $912.24K | -4.3% |
| 2016 | Dec 30, 2016 | $952.74K | -49.9% |
| 2015 | Dec 31, 2015 | $1.90M | -92.0% |
| 2014 | Dec 31, 2014 | $23.75M | -27.5% |
| 2013 | Dec 31, 2013 | $32.78M | -30.0% |
| 2012 | Dec 31, 2012 | $46.85M | – |
See a number that looks wrong?